Robert Frenck

Vaccinology Training Program

National Institute of Allergy and Infectious Diseases · T32

PI · $1.4M · Cincinnati Childrens Hosp Med Ctr

Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)

National Institute of Allergy and Infectious Diseases · UM1

Contact PI · $20.5M · Cincinnati Childrens Hosp Med Ctr

Task 12: Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae

NIH Office of the Director · N01

Contact PI · $15.3M · University of Alabama at Birmingham

A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine

Principal investigator · Active not recruiting · Phase 2

LimmaTech Biologics AG

Safety and Immunogenicity of a Nipah Virus Vaccine

Principal investigator · Completed · Phase 1

Auro Vaccines LLC

Dose-Finding Study of Lyophilized Shigella Sonnei 53G Challenge Strain

Principal investigator · Completed · Phase 1

PATH

Susceptibility of Human Volunteers With Different Histo-Blood With Different Histo-Blood Group Antigens to Norovirus

Principal investigator · Completed · Phase 1

Children's Hospital Medical Center, Cincinnati